Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism

2015 ◽  
Vol 3 (12) ◽  
pp. 993-1003 ◽  
Author(s):  
Murray Epstein
2018 ◽  
Vol 121 ◽  
pp. 124-133 ◽  
Author(s):  
Benjamin Bonnard ◽  
Marie Pieronne-Deperrois ◽  
Zoubir Djerada ◽  
Soumaya Elmoghrabi ◽  
Peter Kolkhof ◽  
...  

2020 ◽  
Vol 71 (6) ◽  
pp. 194-204
Author(s):  
Teim Baaj ◽  
Ahmed Abu-Awwad ◽  
Mircea Botoca ◽  
Octavian Marius Cretu ◽  
Elena Ardeleanu ◽  
...  

Organ damages, which contribute to the overall cardiovascular risk of hypertensive patients, should be early detected, prevented and treated. The study evaluated organ damage in a hypertensive study group with chronic kidney disease (CKD), compared with a study group of hypertension without CKD. Albuminuria was present in 41.2% and reduced estimated glomerular filtration rate [60 ml/min/m2 was present in 72.5% of hypertensive with CKD. The comparison of organ damage revealed in the CKD group a statistical significant higher prevalence of organ damage as follows: intima-media thickness ]0.9 mm in 39.9% vs 10.5%, carotid plaques in 28.2% vs 12.6%, left ventricular hypertrophy in 39.9% vs 31%, ankle brachial index in 6.2% vs 3.5%. Early detection and treatment of additional cardiovascular risk factors as dyslipidaemia and hyperglycaemia, that have significant role in the pathogenesis of organ damage, contribute to the better prevention of cardiovascular and renal complications in hypertension with CKD.


Sign in / Sign up

Export Citation Format

Share Document